Market revenue in 2023 | USD 3,089.1 million |
Market revenue in 2030 | USD 7,416.2 million |
Growth rate | 13.3% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.81% in 2024. Horizon Databook has segmented the Europe biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounts for a considerable revenue share of the biochip market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have advanced infrastructure, which is anticipated to significantly boost clinical research prospects in the region.
Moreover, the market growth can be attributed to a growing biotechnology industry and rising investments in genomic sequencing in countries such as the UK & Germany. The population in Europe is rapidly aging. According to the UN, individuals aged over 65 make up 19% of the population, which represents approximately 183 million people.
This population is at a higher risk of developing infectious diseases, as they have a greater likelihood of developing flu and being hospitalized. Thus, owing to these factors, the region is expected to witness significant growth opportunities during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biochip market, including forecasts for subscribers. This continent databook contains high-level insights into Europe biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account